ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Keri Losavio

Editor Keri Losavio has been a professional editor and writer in the medical and financial fields for 20 years and joined the Wiley team in February 2014. She has written for and edited newsletters, magazines, personal memoirs, book proposals, dissertations, textbooks and more.

Articles by Keri Losavio

The Rheumatologist Honored with 2 Awards of Excellence

  |  

We are honored to announce that The Rheumatologist has received two Awards of Excellence from APEX 2023 for content published in calendar year 2022: an Award of Excellence in the category of Public Health Concerns—Health & Medical for the editorial supplement to the April issue, COVID-19: What We Know, and an Award of Excellence for…

Sarilumab Approved for the Treatment of Adults with Glucocorticoid-Resistant PMR

  |  

First described in 1888, polymyalgia rheumatica (PMR) is a chronic inflammatory condition that almost exclusively affects individuals older than 50.1 Until this week, no therapies for PMR had been approved by the U.S. Food & Drug Administration (FDA).2 Tuesday, Sanofi announced sarilumab (Kevzara) has been approved by the U.S. Food & Drug Administration for the…

In Memoriam: A Tribute to Dr. Philip Robinson

The COVID-19 Global Rheumatology Alliance Steering Committee: Jinoos Yazdany, MD, MPH; Zachary S. Wallace, MD, MSc; Paul Sufka, MD; Emily Sirotich, PhD; Pedro Machado, MD, PhD, FRCP; Jean Liew, MD, MS; Jonathan Hausmann, MD; Rebecca Grainger, MB ChB, PhD; Monique Gore-Massy; & Suleman Bhana, MD, FACR  |  

We write to celebrate the life of Philip C. Robinson, MB ChB, PhD, FRACP, a beloved colleague and leader in rheumatology. Phil died in early January after an unexpected and short illness. He is survived by his wife, Helen, and his two young sons. We have witnessed an incredible outpouring of respect and affection for…

Please Hear Me: How Effective Provider-Patient Communication Improved My Psoriatic Arthritis

Ashley Krivohlavek  |  

PHILADELPHIA—“At age 12, I was diagnosed with psoriasis (PsO), followed by a diagnosis of psoriatic arthritis (PsA) at age 30,” said Ashley Krivohlavek of Oklahoma City in a poster presentation at ACR Convergence 2022. “I’m now 38.”   Ms. Krivohlavek’s Story In 2020, I had been on an infused biologic for 18 months, but my…

From Denial of Spondyloarthritis to a Support Group Leader & Medical Doctor of Rheumatology: A Patient’s Perspective

Shung Ming Chiu, MD  |  

PHILADELPHIA—“My symptoms started in the final year of medical school, and at that stage I believed I was strong enough to fight my condition,” said Shung Ming Chiu, MD, in a poster presentation at ACR Convergence 2022. “Later, I realized that it’s not [about] fighting [but] rather accepting it and adapting to the new normal….

Gout Research at a Glance

Lisa Stamp, MBChB, FRACP, PhD  |  

PHILADELPHIA—Approximately 60 research abstracts on gout were accepted for presentation at ACR Convergence 2022, including two plenary abstract presentations. It is exciting to see a wealth of research on gout being undertaken worldwide. Here, we highlight important points from seven of these studies. 1. Abstract 1810: Frequency and Patterns of Opioid Use in the Management…

Top Research in Axial Spondyloarthritis Presented at ACR Convergence 2022

David S. Pisetsky, MD, PhD  |  

PHILADELPHIA—Approximately 100 research abstracts on axial spondyloarthritis (axSpA) were accepted for presentation at ACR Convergence 2022. It is exciting to see a wealth of research on axSpA being undertaken worldwide. Here, we highlight important points from 10 of these studies. 1. Abstract 0378: Prevalence of Axial Spondyloarthritis (axSpA) in Patients Treated for Chronic Back Pain…